Brexit and the Impact to Your Global Business Operations
What Life Sciences Companies Need to Know Now

Thursday, Nov. 1, 2018 · 1:30 p.m. - 3:00 p.m. EDT

Your international drug and device business is at a crossroads known as Brexit — the withdrawal of the United Kingdom (UK) from the European Union (EU).

What can you expect?

The EMA is moving to from London to Amsterdam in March 2019 — and will lose a 30 percent of its staff. The agency has already stopped accepting and publishing clinical trials data.

What about the legal uncertainty regarding contracts involving both the UK and other EU member states?

Brexit is about to happen and you need to make plans before it does. Prepare to discover:

  • The impact on international harmonization efforts — the EMA will “only take a reactive role,” focus on “urgent” drug safety guidelines and limit travel to “Brexit-related interactions.”
  • How to deal with the legal uncertainty introduced into contracts involving both the UK and EU member states
  • And much more…

Brexit will be finalized on March 29, 2019. You need to know how it will impact your global operations. Register today to minimize potential disruptions. Register today.

Who Will Benefit

Any quality or regulatory professional at a life sciences company with operations involving the European Union and the United Kingdom including:

  • President
  • Vice President
  • Operations Managers
  • Supplier Managers
  • Regulatory Affairs
  • Quality Assurance

Webinar plus Audio Recording/Transcript
Learn more

$487

add to cart

Webinar only
Learn more

$287

add to cart

24/7 Encore plus Audio Recording/Transcript
Learn more

$487

add to cart

24/7 Encore Presentation
Learn more

$287

add to cart

Audio Recording/Transcript
Learn more

$287

add to cart

 

 

 

Meet Your Presenter

Michael Burke

Partner, Corporate Practice
Arnall Golden Gregory

Michael Burke provides practical and actionable legal and compliance guidance that allows companies to focus on business growth. He helps companies minimize risk and maximize return across a wide range of domestic and cross-border corporate and commercial transactions and regulatory issues. Mike is a partner in the Corporate Practice and co-chairs Arnall Golden Gregory’s Pharmaceuticals and Medical Devices Industry Team. Mike co-chairs the American Bar Association-United Nations Development Programme International Legal Resource Center and is the immediate past chair of the American Bar Association’s Section Officer’s Conference.

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA.

Phone (703) 538-7600 | Fax (703) 538-7676 | Toll free (888) 838-5578 | Email customerservice@fdanews.com

© 2018 FDAnews